// App-Quantinova.ai

: INNV-10. SAFETY OF APIXABAN FOR VENOUS THROMBOEMBOLISM PREVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Researchers

Presenter

  • Alissa Thomas

Principal Investigators

  • Heather Wright

  • Hannah Walker

  • Prachi Prasad

  • Kelly Chan

  • Eswar Tipirneni

  • Andrew Goodwin

  • Chris Holmes

Medical Centers

  • University of Vermont College of Medicine, South Burlington, VT

  • Central Vermont Medical Center, Berlin, VT, USA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Gliomas

  • Glioblastoma

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

  • Heparin

Outcome

  • N/A

Study Design

  • Open Label

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved